Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUSO: Saline vs Saline + Ondansetron Lavage in Laparoscopic Cholecystectomy
NCT06632184Phase 4Active, not recruiting
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of ondansetron in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoint: Area Under the Curve of Visual Analog Scale Scores at 24 hours. Started Dec 2025; status: active, not recruiting.
02
Drugs
ondansetron
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06632184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06632184.